PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
- Авторлар: Rudakova AV1, Rudakova A.V.1
-
Мекемелер:
- Шығарылым: № 16 (2010)
- Беттер: 71-72
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278647
- ID: 278647
Дәйексөз келтіру
Толық мәтін
Аннотация
Sulfonylurea medications are widely used in the treatment of patients with type 2 diabetes mellitus in Russia. The study was aimed to evaluation of pharmacoeconomic aspects of use of II generation sulfonylurea medications. The evaluation was based on the results of GUIDE study, which compared gliclazide with modified release (Diabeton MV) and glimepiride (Amaryl). Drugs are characterized by equal clinical efficacy, but frequency of hypoglycaemia was significantly lower against the background of therapy with gliclazide. Cost analysis showed that therapy with gliclazide leads to more than 40% savings. Thus, gliclazide with modified release is economically more justified choice in the group of sulfonylurea compared with glimepiride.
Әдебиет тізімі
- Bolen S, Feldman L, Vassy J, et al. Systematic Review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007;147:386-99.
- Шведова А.М. Фармакоэпидемиологическая и фармакоэкономическая оценка пероральной сахароснижающей терапии сахарного диабета типа 2 в амбулаторной практике. Дисс. канд. мед. наук. М., 2006. С. 23.
- ЦМИ "Фармэксперт". Отпуск ЛС по программе льготного лекарственного обеспечения. www.pharmexpert.ru
- Zammitt N, Frier B. Hypoglycemia in Type 2 Diabetes. Pathophysiology, frequency, and effects of different treatment modalities. Diabetes care 2005;28(12):2948-61.
- Schernthaner G, Grimaldi A, Di Mario U, et al. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. European Journal of Clinical Investigation 2004;3:535-42.
- Приложения к Генеральному тарифному соглашению по тарифам на медицинскую помощь (медицинские услуги) и условиям оплаты медицинской помощи, оказываемой в рамках действующей Территориальной программы обязательного медицинского страхования граждан Российской Федерации в Санкт-Петербурге на 2010 г. (www.spboms.ru).
Қосымша файлдар
